Canopy, the leader in Enterprise AI for Oncology, today announced findings on the potential of its EHR-integrated Remote Therapeutic Monitoring (RTM) Platform to reduce infection-related ...
Livewire Markets on MSN
2 global stocks Canopy believes are positioned for long-run compounding
Canopy Investors breaks down where quality global growth exists today and why so much of it lies outside the U.S.
Detailed price information for Canopy Growth Corp (CGC-Q) from The Globe and Mail including charting and trades.
Barchart on MSN
Canopy Growth Just Topped Earnings Estimates. Should You Buy, Sell, or Hold CGC Stock for November 2025?
On Friday, Nov. 7, investors shifted their focus to Canopy Growth (CGC), a Canada-based global leader in cannabis and ...
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Canopy Growth reported improved financial results for Q2, with higher revenue and improved net loss. Find out why CGC stock ...
Canopy, based in Smiths Falls, Ont., produces and sells medical cannabis and cannabinoid-based consumer products in Canada ...
Detailed price information for Canopy Growth Corp (CGC-Q) from The Globe and Mail including charting and trades.
Aurora Cannabis reports Q2-2026 revenue growth with stronger international sales but posts net loss and negative free cash flow. Learn why ACB stock is a hold.
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (Nasdaq: CGC) today announced its financial results for the second quarter ended September 30, 2025 ("Q2 FY2026"). All financial ...
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback